Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs are medications used to treat viral infections by inhibiting the development of viruses. In Russia, the Antiviral Drugs market has been experiencing a steady growth in recent years.
Customer preferences: The demand for Antiviral Drugs in Russia is mainly driven by the increasing prevalence of viral infections such as HIV, hepatitis, and influenza. Patients suffering from these diseases require antiviral drugs to manage their conditions. Additionally, the rising awareness of the effectiveness of antiviral drugs in treating viral infections has also contributed to the growth of the market.
Trends in the market: One of the major trends in the Antiviral Drugs market in Russia is the increasing adoption of generic antiviral drugs. This is due to the lower cost of generic drugs compared to branded drugs. As a result, patients are more likely to opt for generic drugs, which has led to an increase in the demand for these drugs.Another trend in the market is the development of new antiviral drugs. Pharmaceutical companies are investing in research and development to create new drugs that are more effective in treating viral infections. This has led to the introduction of new antiviral drugs in the market, which has further fueled the growth of the market.Local Special circumstances: Russia has a high prevalence of viral infections, which has led to an increase in the demand for antiviral drugs. Additionally, the Russian government has implemented several initiatives to improve the healthcare system in the country. This has led to an increase in the availability of antiviral drugs in the market.
Underlying macroeconomic factors: The Russian economy has been recovering from the economic crisis of 2014-2015. This has led to an increase in the purchasing power of consumers, which has contributed to the growth of the Antiviral Drugs market. Additionally, the government has implemented several policies to promote the growth of the pharmaceutical industry in the country. This has led to an increase in the production of antiviral drugs, which has further fueled the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
